Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR13D1 Inhibitors

OR13D1 inhibitors are a distinct class of chemical compounds specifically designed to target the OR13D1 receptor, a member of the olfactory receptor family within the G-protein-coupled receptor (GPCR) superfamily. Olfactory receptors like OR13D1 are primarily involved in the detection of odor molecules, a function that is central to the sense of smell. However, olfactory receptors are also expressed in a variety of non-olfactory tissues, indicating that they may have additional roles in different biological processes. OR13D1 inhibitors function by binding to this receptor, thereby blocking or modulating its ability to interact with natural ligands. This inhibition can lead to changes in the signaling pathways controlled by OR13D1, which can influence a range of physiological functions. Research into OR13D1 inhibitors is crucial for gaining a better understanding of the receptor's roles in non-olfactory tissues, where its functions are not yet fully understood. The chemical nature of OR13D1 inhibitors is diverse, with various compounds exhibiting different structural characteristics and mechanisms of action. Some inhibitors are competitive antagonists that directly bind to the receptor's active site, preventing natural ligands from activating the receptor and initiating a signaling cascade. This type of interaction effectively blocks the receptor's normal function. Other inhibitors may work allosterically, binding to sites on the receptor other than the active site and inducing conformational changes that alter the receptor's activity or its signaling dynamics. The development and optimization of OR13D1 inhibitors typically involve advanced structural biology techniques, such as X-ray crystallography, cryo-electron microscopy, and molecular modeling. These methods are essential for identifying critical binding sites on the receptor and for designing inhibitors that are both potent and highly selective. Researchers aim to create OR13D1 inhibitors that specifically target this receptor without affecting other GPCRs or unrelated proteins, ensuring that their effects are focused and precise. By studying these inhibitors, scientists can explore the broader biological roles of OR13D1 in various systems and investigate how modulating its activity can impact different cellular processes.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$149.00
$210.00
$714.00
$2550.00
$10750.00
$21410.00
$40290.00
5
(1)

Blocks G-protein interactions, can prevent OR13D1 from initiating signal transduction.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$103.00
$293.00
$465.00
15
(1)

Protein kinase C inhibitor, can alter phosphorylation pathways of OR13D1.

Mibefradil dihydrochloride

116666-63-8sc-204083
sc-204083A
10 mg
50 mg
$209.00
$848.00
4
(1)

T-type calcium channel blocker, can affect downstream signaling pathways of OR13D1.

ML-7 hydrochloride

110448-33-4sc-200557
sc-200557A
10 mg
50 mg
$89.00
$262.00
13
(1)

Myosin light chain kinase inhibitor, can affect cytoskeletal changes related to OR13D1 signaling.

KN-93

139298-40-1sc-202199
1 mg
$178.00
25
(1)

CaMKII inhibitor, can prevent calcium-dependent signaling related to OR13D1.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

MAP kinase inhibitor, can disrupt downstream effects of OR13D1 activation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

p38 MAP kinase inhibitor, can inhibit signaling pathways associated with OR13D1.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

ROCK inhibitor, can affect G-protein signal transduction linked to OR13D1.

2-APB

524-95-8sc-201487
sc-201487A
20 mg
100 mg
$27.00
$52.00
37
(1)

IP3 receptor blocker, can interfere with calcium signaling of OR13D1.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$103.00
$237.00
36
(1)

PKC inhibitor, can prevent OR13D1-related phosphorylation events.